A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial

A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial

Abstract Background Primary surgery is usually the mainstay treatment in early-stage oropharyngeal and oral cavity cancer. Typically, neck surgery is performed. Negative tumor margins are recommended (> 5 mm). If feasible, re-resection of any positive margin is preferred. Otherwise, postoperative...

Full description

Bibliographic Details
Main Authors: Julian Biau, Emilie Thivat, Corinne Millardet, Nicolas Saroul, Nathalie Pham-Dang, Ioana Molnar, Bruno Pereira, Xavier Durando, Jean Bourhis, Michel Lapeyre
Format: Article
Language:English
Published: BMC 2020-08-01
Series:BMC Cancer
Subjects:
Oropharyngeal and Oral cavity cancers
Hypofractionated stereotactic body radiotherapy (SBRT)
Postoperative radiotherapy
Online Access:http://link.springer.com/article/10.1186/s12885-020-07231-3

Internet

http://link.springer.com/article/10.1186/s12885-020-07231-3

Similar Items